email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2671 - 2685
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
CANbridge Forms Rare Disease Drug Partnership with WuXi Biologics
$5.00
Available
Fosun Acquires China Rights to HCC Diagnostic with $10 Million Glycotest Investment
$5.00
Available
CASI Pharma Acquires HBV Treatment for China Use from Indian Pharma
$5.00
Available
Jiangsu Hengrui Forms Global Clinical Collaboration with LSK BioPharma
$5.00
Available
China Everbright Raises $155 Million for Third Life Science Fund
$5.00
Available
Zai Lab Ok'd to Launch PARP Inhibitor in Hong Kong
$5.00
Available
Reistone of Shanghai Approved for US Phase II Trial of UC Treatment
$5.00
Available
Genecast Acquires China Rights to Tumor Test from Cancer Genetics
$5.00
Available
Ascletis's Second HCV Treatment on Priority Review List in China
$5.00
Available
Singlera Reports Positive Results from Blood-based Diagnostic for Colorectal Cancer
$5.00
Available
Chi-Med Starts China Trials of Syk Inhibitor in Acute Myeloid Leukemia Patients
$5.00
Available
Alphamab to Start US Phase I Clinical Trial of HER2 Bispecific Antibody
$5.00
Available
iCell Partners with LineaRx for new CAR-T Manufacturing Platform
$5.00
Available
CStone Approved to Start US Trials of PD-L1 Candidate
$5.00
Available
Innovent to Raise $422 Million in Hong Kong IPO at $2 Billion Valuation
$5.00
Available